Sponsors (18)
The bill increases food-safety oversight and transparency that can remove harmful additives and improve scientific review, but it could raise compliance costs and consumer prices and strain FDA resources.
Consumers (including parents and children) may see unsafe food additives removed from the market because FDA must amend or revoke approvals and premarket notifications when reassessments find substances unsafe.
Consumers — especially parents and low-income families — gain more timely, public safety information because the FDA must reassess and post determinations for at least 10 food-related substances every 3 years beginning in 2026.
Hospitals, health systems, and the public benefit from strengthened scientific guidance because reestablishing the Food Advisory Committee provides expert input to improve reassessment standards and methods.
Low-income families and shoppers could face higher food prices if revocations of certain additives increase production costs that manufacturers pass on to consumers.
Small food manufacturers and other businesses may incur increased compliance and reformulation costs if the FDA revokes approvals or notifications following reassessments.
Federal employees and the FDA could face increased workload and resource strain from frequent (every 3 years) reassessments, which could slow reviews of new products or require additional agency resources.
Based on analysis of 2 sections of legislative text.
Requires FDA to reassess food additives, color additives, GRAS, prior‑sanctioned, and food contact substances at least every 3 years, publish determinations, and act on unsafe substances.
Introduced July 10, 2025 by Janice D. Schakowsky · Last progress July 10, 2025
Requires the Food and Drug Administration to run a continuous program that reassesses food-related substances (food additives, color additives, GRAS substances, prior-sanctioned substances, and food-contact substances) at least once every 3 years starting in 2026. The FDA must publish each reassessment, prioritize by public health need, reestablish an expert advisory committee to set standards and methods, and take specific follow-up actions if a substance is found not safe, including amending or revoking approvals or notifications.